DRKS00003715已完成不适用
Efficacy and safety of the therapy of a disease involving a primary melanoma on a long-term basis (Health Services Research MELANOMA)
ADO Tübingen0 个研究点目标入组 1,353 人开始时间: 2016年1月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,353
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •Patient who has been diagnosed with new onset skin cancer (= primary melanoma) in the in the period from 01.04.08-31.06.08
排除标准
- •no further information
研究者
相似试验
尚未招募
3 期
Safety and Efficacy of Rifampicine 600 mg, Moxifloxacine 400mg and Minocycline 100 mg for leprosy patients: An open ended randomized trialCTRI/2019/02/017812Indian Council of Medical Research
尚未招募
1 期
euroEPO – Type 2 Spinocerebellar Ataxia Phase I-IIType 2 Spinocerebellar AtaxiaRPCEC00000187Center of Molecular Immunology (CIM), CIMAB34
进行中（未招募）
1 期
Evaluation of the safety and efficacy of the treatment of chronic wounds in diabetic foot syndrome with the use of autologous stem cells isolated from adipose tissue - within the project: Therapeutic potential of adipose-derived stem cells, proven in clinical trials and examined in vitro - rationale for banking of well characterized cells”MedDRA version: 20.0 Level: LLT Classification code 10012664 Term: Diabetic foot ulcer System Organ Class: 100000004858Diabetic foot ulcerEUCTR2016-004109-15-PLMedical University of Warsaw50
进行中（未招募）
1 期
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)MedDRA version: 18.0Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858EUCTR2014-001815-38-DEAllergan Limited750
进行中（未招募）
1 期
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown LinesFacial Rhytides (Forehead Lines, Glabellar Lines)MedDRA version: 18.1Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858EUCTR2014-001860-36-IEAllergan Limited400